Advanced search

Find pages with...
Then narrow your results by...

About 77 search results

Health Canada updates Canadians on shortage situation involving EpiPen (0.3 mg) auto-injectors

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/67330a-eng.php

Jul 30, 2018 ... following the administration of the product, as instructed in the product labelling. Pfizer Canada informed Health Canada that the current shortage is due to a manufacturing issue with the EpiPen 0.3 mg format. Pfizer Canada is asking healthcare professionals to help manage the supply and pharmacists to keep this current supply situation in mind when dispensing

Alesse 21 and 28 birth control pill: Packages may contain broken or smaller-than-normal pills, which may reduce effectiveness in preventing pregnancy

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2017/65306a-eng.php

Dec 2, 2017 ...Alesse 21 and 28 birth control pill: Packages may contain broken or smaller-than-normal pills, which may reduce effectiveness in preventing pregnancy Report a Concern Starting date: December 1, 2017 Type of communication: Advisory Subcategory: Drugs Source of recall: Health Canada Issue: Important Safety Information, Labelling and Packaging Audience

NON-VENTED DISPENSING PIN (2016-04-14)

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2016/58362r-eng.php

May 25, 2016 ..., Hospitals Identification number: RA-58362 Reason Affected products Affected products NON-VENTED DISPENSING PIN Reason B. Braun Medical Inc. has identified a potential for a tear in the outer blister packaging on a limited number of units. The tears have been identified in the blister package paper, where the unit label writing is located. A tear results

Safety information for antipsychotic drug Abilify and risk of certain impulse-control behaviours

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/55668a-eng.php

Nov 2, 2015 ... request alternate formats by contacting us. Safety information for antipsychotic drug Abilify and risk of certain impulse-control behaviours Report a Concern Starting date: November 2, 2015 Posting date: November 2, 2015 Type of communication: Information Update Subcategory: Drugs Source of recall: Health Canada Issue: Product label update Audience: General Public

Search results

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/search-recherche/simple?js_en=&page=1000&per_page=21000&plain_text=&s=

Mar 30, 2012 ... Relax Tropical Oasis MSM and Echinacea Tropical Oasis Raspberry Aid Copper and Zinc - Liquid (December 21, 2007) Wild Vineyard does not have a site licence to manufacture, package, label or import natural health products in Canada., as required by section 27(1) of the Natural Health Product Regulations. Products made by Wild Vineyard have not been manufactured

Search results

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/search-recherche/simple?js_en=&page=1000&per_page=20000&plain_text=&s=

Mar 30, 2012 ...: 20001-21000 of 30630 Previous Next CMI issued a recall on the STRIKER model CMI issued a recall on the STRIKER model On certain Limited Speed Motorcycles, the compliance label incorrectly indicates a manufacturing date of 12/2008 but instead should read 12/2007. Correction: Dealers will install updated labels. Defect, Investigation, Vehicle, Recalls... Posted

Archive – Update to April 22, 2005 Advisory Entitled: Health Canada Advises Consumers to Verify Their Medication

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2005/13687a-eng.php

May 1, 2013 ..., Labelling and Packaging Audience: Healthcare Professionals, General Public Identification number: RA-11000587 Related AWRs Media enquiries Public enquiries Health Canada is providing an update to its advisory issued on April 22, 2005, which addressed problems with the packaging process for drugs produced at a Puerto Rico manufacturing plant. Canadians were advised

Health Canada Releases Important Information on the Dispensation of CLOZAPINE Products in Canada – Notice to Hospitals

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2004/14250a-eng.php

Jun 5, 2013 .... These revisions will strengthen the labeling and address ongoing issues around patient consent for the sharing of information between registries, considered important due to the well-known risk of agranulocytosis associated with clozapine use. Revisions to clozapine Product Monographs will emphasize the following: the switching of a patient from one brand of clozapine

Stander (Tilt Standing Frame) – Safety Warning Label Addition – For the Public

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2010/14088a-eng.php

... to be in place before lifting a patient. Individuals should never be left unattended while in the Tilt Standing Frame. Tilt Standing Frames are dispensed with written use instructions, which must be followed at all times when using the unit. Supplemental warning labels have been developed by the Rehabilitation Centre for Children for placement on the Tilt Standing Frame

Search results

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/search-recherche/simple?js_en=&page=1000&per_page=11000&plain_text=&s=

Mar 30, 2012 ... may not comply with the requirements of Canada Motor Vehicle Safety Standard 110 - Tire Selection and Rims. The Tire and Loading Information label may contain misspelled words in French. Correction: Owners will be supplied with a revised Tire... Posted: 2014-02-26 Type of communication: Recall Malley's brand Dry Garlic Ribs recalled due to undeclared mustard

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: